These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 15345317)
1. The novel histone deacetylase inhibitor BL1521 inhibits proliferation and induces apoptosis in neuroblastoma cells. de Ruijter AJ; Kemp S; Kramer G; Meinsma RJ; Kaufmann JO; Caron HN; van Kuilenburg AB Biochem Pharmacol; 2004 Oct; 68(7):1279-88. PubMed ID: 15345317 [TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitor BL1521 induces a G1-phase arrest in neuroblastoma cells through altered expression of cell cycle proteins. Ouwehand K; de Ruijter AJ; van Bree C; Caron HN; van Kuilenburg AB FEBS Lett; 2005 Feb; 579(6):1523-8. PubMed ID: 15733867 [TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling in response to the histone deacetylase inhibitor BL1521 in neuroblastoma. de Ruijter AJ; Meinsma RJ; Bosma P; Kemp S; Caron HN; van Kuilenburg AB Exp Cell Res; 2005 Oct; 309(2):451-67. PubMed ID: 16084510 [TBL] [Abstract][Full Text] [Related]
4. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells. Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934 [TBL] [Abstract][Full Text] [Related]
5. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Hsi LC; Xi X; Lotan R; Shureiqi I; Lippman SM Cancer Res; 2004 Dec; 64(23):8778-81. PubMed ID: 15574791 [TBL] [Abstract][Full Text] [Related]
6. Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma. Glick RD; Swendeman SL; Coffey DC; Rifkind RA; Marks PA; Richon VM; La Quaglia MP Cancer Res; 1999 Sep; 59(17):4392-9. PubMed ID: 10485488 [TBL] [Abstract][Full Text] [Related]
7. Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia. Romanski A; Bacic B; Bug G; Pfeifer H; Gul H; Remiszewski S; Hoelzer D; Atadja P; Ruthardt M; Ottmann OG Haematologica; 2004 Apr; 89(4):419-26. PubMed ID: 15075075 [TBL] [Abstract][Full Text] [Related]
9. The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells. Mandl-Weber S; Meinel FG; Jankowsky R; Oduncu F; Schmidmaier R; Baumann P Br J Haematol; 2010 May; 149(4):518-28. PubMed ID: 20201941 [TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma. Heider U; Kaiser M; Sterz J; Zavrski I; Jakob C; Fleissner C; Eucker J; Possinger K; Sezer O Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of survivin. De Schepper S; Bruwiere H; Verhulst T; Steller U; Andries L; Wouters W; Janicot M; Arts J; Van Heusden J J Pharmacol Exp Ther; 2003 Feb; 304(2):881-8. PubMed ID: 12538846 [TBL] [Abstract][Full Text] [Related]
12. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Vigushin DM; Ali S; Pace PE; Mirsaidi N; Ito K; Adcock I; Coombes RC Clin Cancer Res; 2001 Apr; 7(4):971-6. PubMed ID: 11309348 [TBL] [Abstract][Full Text] [Related]
13. Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation. Park JH; Jung Y; Kim TY; Kim SG; Jong HS; Lee JW; Kim DK; Lee JS; Kim NK; Kim TY; Bang YJ Clin Cancer Res; 2004 Aug; 10(15):5271-81. PubMed ID: 15297431 [TBL] [Abstract][Full Text] [Related]
14. Identification of novel isoform-selective inhibitors within class I histone deacetylases. Hu E; Dul E; Sung CM; Chen Z; Kirkpatrick R; Zhang GF; Johanson K; Liu R; Lago A; Hofmann G; Macarron R; de los Frailes M; Perez P; Krawiec J; Winkler J; Jaye M J Pharmacol Exp Ther; 2003 Nov; 307(2):720-8. PubMed ID: 12975486 [TBL] [Abstract][Full Text] [Related]
15. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells. Ahn MY; Jung JH; Na YJ; Kim HS Gynecol Oncol; 2008 Jan; 108(1):27-33. PubMed ID: 17920664 [TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells. Choi YH Int J Oncol; 2005 Aug; 27(2):473-9. PubMed ID: 16010430 [TBL] [Abstract][Full Text] [Related]
17. Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin. Han JW; Ahn SH; Park SH; Wang SY; Bae GU; Seo DW; Kwon HK; Hong S; Lee HY; Lee YW; Lee HW Cancer Res; 2000 Nov; 60(21):6068-74. PubMed ID: 11085529 [TBL] [Abstract][Full Text] [Related]
18. Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells. Donadelli M; Costanzo C; Faggioli L; Scupoli MT; Moore PS; Bassi C; Scarpa A; Palmieri M Mol Carcinog; 2003 Oct; 38(2):59-69. PubMed ID: 14502645 [TBL] [Abstract][Full Text] [Related]
19. Novel histone deacetylase inhibitors in the treatment of thyroid cancer. Mitsiades CS; Poulaki V; McMullan C; Negri J; Fanourakis G; Goudopoulou A; Richon VM; Marks PA; Mitsiades N Clin Cancer Res; 2005 May; 11(10):3958-65. PubMed ID: 15897598 [TBL] [Abstract][Full Text] [Related]
20. Molecular and cellular basis for the anti-proliferative effects of the HDAC inhibitor LAQ824. Atadja P; Hsu M; Kwon P; Trogani N; Bhalla K; Remiszewski S Novartis Found Symp; 2004; 259():249-66; discussion 266-8, 285-8. PubMed ID: 15171259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]